Sclerostin binding antibodies
US9296812B2 · kind B2 · utility
7Cited by
55References
16Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Nov 30, 2012 |
| Grant date | Mar 29, 2016 |
| Priority date | — |
| Expiry date | Sep 1, 2034 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compositions and methods relating to epitopes of sclerostin protein, and sclerostin binding agents, such as antibodies capable of binding to sclerostin, are provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.